Reponse to: comment on, 'Tumour-stroma ratio (TSR) in oestrogen-positive breast cancer patients'.
Leeds Institute of Cancer & Pathology, University of Leeds, St James's University Hospital, Leeds LS9 7TF, UK.
C L
CL
Downey
Leeds Institute of Cancer & Pathology, University of Leeds, St James's University Hospital, Leeds LS9 7TF, UK.
S A
SA
Simpkins
Leeds Institute of Cancer & Pathology, University of Leeds, St James's University Hospital, Leeds LS9 7TF, UK.
D L
DL
Holliday
Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, London, UK.
J L
JL
Jones
Department of Pathology, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK.
L B
LB
Jordan
2nd Department of Pathology, Semmelweis University Budapest, Üllői út 93 1091, Hungary.
J
J
Kulka
Leeds Institute of Cancer & Pathology, University of Leeds, St James's University Hospital, Leeds LS9 7TF, UK.
A M
AM
Hanby
Leeds Institute of Cancer & Pathology, University of Leeds, St James's University Hospital, Leeds LS9 7TF, UK.
V
V
Speirs
D001943:Breast Neoplasms / Q000175:diagnosis*; D018567:Breast Neoplasms, Male / Q000175:diagnosis*; D005260:Female; D006801:Humans; D008297:Male; D011960:Receptors, Estrogen / Q000378:metabolism*; D047368:Tumor Burden
D011960:Receptors, Estrogen